In addition, RANKL is documented to be strongly repressed by PAX5, which is a critical B-lymphoid transcription factor, and genetic lesions in PAX5 are widespread in pre-B ALL, generally leading to reduced expression [46–48]. This evidence concerns the gene TNFSF11 and acute lymphoblastic leukemia.